Overview and technical details of a 3-dimensional bioplotter for production of intestinal crypt organoid models.
The intestine is divided into two sections: the small intestine and the large intestine, or colon. The inner surface of each is lined by a simple epithelium and endothelium, separated by a basement membrane. While the small intestine epithelium is comprised of crypts and villus structures for the absoprtion of micronutrients, the colon only has crypts on its epithelial surface and primarily functions to compact the stool. Although there are differences between the two sections, the role of the crypt is the same: house the stem cells in the bottom third of the structure so they can differentiate upward towards the lumen.
Each of the intestinal cell types are differentiated from the Lgr5+ stem cells in the bottom of the crypt. In the organoid model, the cells can be grown along a crypt-villus axis, with the capability of sampling the cellular milieu directly. However, the organoid model falls short of recapitulating the in vivo physiology and pathology of the human body.
Epithelial Cell Type | Function | Biomarker |
---|---|---|
Enterocyte | Absorption, most abundant | SLC10A2 - Bile Acid Transporter |
Goblet | Mucus secreting | TFF3 - Trefoil Factor 3 |
Enteroendocrine | Hormone production | CHGB - Chromogranin B |
Tuft | Prostanoid production, Pathogen elimination | DCLK1 - Microtubule kinase |
Paneth | Nurtures ISCs in crypt | DEFA5 - Defensin Alpha 5 |
M-cell | Antigen transport | GP2 - Glycoprotein 2 |
SnapShot:The Intestine, Cleavers, 2013
The disruption of the intestinal barrier results in intestinal permeability which facilitates translocation of harmful substances and pathogens to the bloodstream, causing disruption of homeostasis. As such, drug and toxin studies across the intestinal barrier are pertinent to gastrointestinal medicine. Our bio-printed organoid model offers the possibility of recreating a physiologically realistic tissue microenvironment for a breadth of gastrointestinal cells spanning all intestinal cell types.
Existing approaches for studying biological systems have focused largely on either whole organism studies or traditional cell culture. Using cell studies that grow one or two cell types in culture either in a Petri dish or in Transwells cannot provide a healthy and controlled microenvironment for multiple cell types. Animal models do not always hold the same biological characteristics and relevance. While the organ-on-a-chip or microphysiological systems approach would target a degree of complexity and validity between the animal and cell culture approaches, chip models make cell retrieval nearly impossible without first lysing the cells. The approach of isolating the several cell types most important to biological processes through human-derived organoids is novel and potentially very powerful.
How do you validate the self-assembly of the ISCs and crosslinking of gels?
Identification of an epithelial monolayer with polarized nuclei (DAPI) and functional Goblet cells (Trefoil Fator 3) will be validated using hematoxylin and eosin (H&E) staining. Below are a few ways to further validate crypt morphology, stability, and cross-linking of the gel.
The addition of human intestinal microvasculature endothelial cells could dramatically extend the complexity of the system by incorporating an immune component via primary monocytes differentiated into macrophages and dendritic cells, and making the analysis of host-microbiome interactions possible.
Organoids derived from human tissue biopsies can be grown, frozen, and revived for multiple reuses, establishing a consistent bio-bank for reproducible experiments and potentially advancing personalized medicine. However, organoids are limited in that they lack the endothelial compartment, containing immune cells, which are pertinent to drug transport, microbiome development, pharmacokinetic analysis, and diease modeling.
Method for Isolating Gut Endothelium Cells